An audit of topiramate use in a general neurology clinic
- 1 June 1998
- Vol. 7 (3) , 207-211
- https://doi.org/10.1016/s1059-1311(98)80037-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsyEpilepsy Research, 1996
- New antiepileptic drugs: a systematic review of their efficacy and tolerabilityBMJ, 1996
- Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial EpilepsyEpilepsia, 1996
- Safety of Topiramate: Adverse Events and Relationships to DosingEpilepsia, 1996
- Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial SeizuresEpilepsia, 1996
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosagesNeurology, 1996
- TOPIRAMATE < Rec INN; USAN >Drugs of the Future, 1989
- Classification of the epilepsies AN INVESTIGATION OF 1,508 CONSECUTIVE ADULT PATIENTSActa Neurologica Scandinavica, 1978
- Psychiatric symptom profiles of patients with epilepsy: a controlled investigationPsychological Medicine, 1975